• 2011 FDA Biopharmaceutical Approvals: Low Number And Economic Impact, But A Record Number Of Orphan Approvals And Many Innovations
• Mylan Receives Tentative FDA Approval For Generic Version Of Lipitor®
• Bayer Initiates Expanded Access Program For Investigational Compound Radium-223 Chloride
• Del Mar Pharmaceuticals Granted U.S. Orphan Drug Designation For VAL-083 For The Treatment Of Glioma
• AstraZeneca’s New Restructuring Initiatives To Drive Productivity And Support Innovation

More Headlines...

• DSM Announces Marketing And Sales Alliance With Indoco
• Norwich Expands Capabilities For Phase I-III Clinical Trials
• ILC Dover’s Sentinel XT™ PAPR Receives NIOSH Approval
• FlexCessory Stand Aids Single-Use Fluid Transfers
• Marken Announces New Corporate Team To Develop Industry Changing Technologies

More News...

• 2.2.12 -- Pharma Beyond Borders: India As An Outsourcing Destination
• 1.31.12 -- Will Illumina Say Yes To Roche's $5.7B Bid?
• 01.26.12 -- 5 Glassware Washing Concerns For Drug Development Labs
• 01.24.2012 -- Manage Lyophilization: How Dry Is Dry Enough?
• 01.19.12 -- Powder Characterization For Modern Manufacturing

More Newsletters...

• FDA Approves KALYDECO (Ivacaftor), The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis
• NPS Pharmaceuticals Announces FDA Acceptance Of New Drug Application For GATTEX (teduglutide) For The Treatment Of Adult Short Bowel Syndrome (SBS)
• Bionest And PMC Address Optimization Of Personalized Medicine Strategies
• Alkermes Initiates Open-Label Pilot Study Of VIVITROL To Evaluate Impact On Re-Arrest And Re-Incarceration In Offenders With History Of Opioid Dependence
• BioLineRx Signs Exclusive License Agreement For BL-8020, An Oral Treatment For Hepatitis C
• Pernix Therapeutics Announces Agreement To License A New FDA-Approved Product To Treat Gastroenterology Disease

More From Business Wire...

• Novavax Acquires New Manufacturing And Office Facilities In Gaithersburg, MD
• Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. And International Medical Systems, Ltd.
• RXi Pharmaceuticals® To Strengthen Strategic Focus By Separating Into Two Publicly Traded Companies
• RXi Pharmaceuticals Licenses Novel, Targeted Cancer Vaccine For Gynecological Cancers
• Progenics Pharmaceuticals Announces Strategic Focus On Oncology
• RXi Pharmaceuticals Provides Positive NeuVax™ Phase 3 Clinical Trial Update
• Bohai Pharmaceuticals Makes Important Acquisition Of Rapidly Growing TCM Company In China
• Sagent Pharmaceuticals Announces FDA Approval Of Polymyxin B For Injection, USP
• Ventrus Announces Improved, FDA-Recommended Endpoints Proposed For Phase III Hemorrhoid Study

More...

Download FREE software, tools, and resources. Our download library is packed with the latest industry releases. Add your demos to the list for FREE.

•	Download software

Browse listings...

What's the industry buzz? Join a discussion forum to find out. Connect with your colleagues…ask questions, share information, discuss recent trends. Join the discussion...

Learn about upcoming industry events. Our events calendar will help you stay current with industry meetings, upcoming conferences, and more. You can also post your industry event and generate highly qualified interest.

•	Search events
•	Post events
•	Stay informed

Learn more...

Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...